• Clene is developing a new class of drugs that hold the potential to transform the lives of millions suffering from debilitating conditions such as Amyotrophic Lateral Sclerosis (“ALS”), Multiple Sclerosis (“MS”), and Parkinson’s Disease (“PD”)
• CNM-Au8(R), Clene’s lead drug candidate, is a fundamentally new approach for treating the underlying factors contributing to ALS, MS, and PD, by restoring neuronal health and function
• ALS, the most prevalent adult-onset progressive motor neuron disease, affects approximately 30,000 people in the U.S.

Clene (NASDAQ: CLNN), a pioneering biopharmaceutical company, is making significant strides in the treatment of neurodegenerative diseases through its novel nanotherapeutic platform. With a mission to improve underlying mitochondrial health and protect neuronal function, Clene is developing a new class of drugs that hold the potential to transform the lives of millions suffering from debilitating conditions such as Amyotrophic Lateral Sclerosis (“ALS”), Multiple Sclerosis (“MS”), and Parkinson’s Disease (“PD”).

At the forefront of Clene’s innovations is CNM-Au8, a gold nanocrystal suspension currently in  development. CNM-Au8 is designed to act as a treatment for ALS, MS, and PD by restoring                neuronal health and function. The drug works by increasing cell energy production and utilization, driving critical cellular reactions that promote neuroprotection and remyelination, thereby enhancing neuronal and glial resilience to disease-related stressors.

In a recent Xtalks podcast, Clene discussed the significant developments of CNM-Au8 and its unique technology. CNM-Au8’s mechanism of action involves the conversion of critical energetic metabolites within living cells to produce ATP, the essential energy currency for cellular functions. The gold nanocrystals attract a coating of apolipoproteins from human plasma, facilitating their passage through the blood-brain barrier and into the brain, where they can protect neurons from death and repair damaged neurons by catalyzing energy production (https://ibn.fm/Gvb5o).

CNM-Au8 is being evaluated in multiple clinical trials, including the prestigious Harvard/MGH HEALEY ALS Platform Trial, which targets patients with mid-to-late stage ALS. The drug has also completed the RESCUE-ALS proof-of-concept clinical trial for early symptomatic ALS, and the REPAIR trials, showing promising changes in brain energy metabolites with CNM-Au8 administration. Additionally, CNM-Au8 has completed a clinical trial, VISIONARY-MS, for treating visual pathway deficits in chronic optic neuropathy, demonstrating its potential for remyelination in stable relapsing MS.

With more than 650 estimated years of collective exposure across ALS, MS, and PD participants in CNM-Au8 clinical trials and Expanded Access Protocol (compassionate use) programs, CNM-Au8 has shown a robust safety profile without any observed safety signals. The drug is designed to be used in combination with other agents and has no known drug-drug interactions, making it a versatile option for patients.

ALS, the most prevalent adult-onset progressive motor neuron disease, affects approximately 30,000 people in the U.S. and an estimated 500,000 people worldwide. Clene estimates that global ALS treatment sales will exceed $1 billion annually in the coming years, underscoring the urgent need for viable treatment options.

Founded in 2013 and based in Salt Lake City, Utah, Clene Inc. is at the forefront of developing innovative treatments for neurodegenerative diseases. With research and development, as well as manufacturing operations in Maryland, Clene is committed to transforming the treatment landscape for ALS, MS, PD, and other debilitating conditions through its groundbreaking nanotherapeutic platform.

For more information, visit the company’s website at www.Clene.com.

NOTE TO INVESTORS: The latest news and updates relating to CLNN are available in the company’s newsroom at https://ibn.fm/CLNN

• The U.S. snack market is predicted to grow to $169.6 billion by 2027
• 93% of adults regularly snack at night combining for over 1 billion bedtime snacks consumed every week.  Unfortunately, the most popular choices are both unhealthy and sleep-disruptive
• Nightfood, with their newly launched sleep-friendly cookie line, is poised to lead the burgeoning sleep-friendly nighttime snack category
• Earlier this month, Nightfood Holdings signed a letter of intent to acquire CarryoutSupplies.com, an established restaurant and foodservice packaging provider that is on the upswing after business suffered greatly during the pandemic

The U.S. snack market is experiencing robust growth, fueled by evolving consumer preferences that prioritize wellness and functionality.  According to Eurometer International, the U.S. snack market will reach $169.6 billion by 2027.  With never-ending social media and video streaming on demand, Americans are staying up later at night and snacking more than ever.

The late-night snacking occasion is a massive and untapped niche within the snack industry. A 2023 Sleep Foundation survey revealed that 93% of American adults snack between dinner and bed each week, with the average adult snacking before bed 3.9 nights per week. The result is over 1 billion nighttime snacks consumed by American adults every week, and a consumer spend estimated at well over $60 billion annually.

A recent survey by Kellanova (NYSE: K), formerly Kellogg Company, revealed that cookies, ice cream, and chips top the list of nighttime snacks. These are not only generally unhealthy, but their sugar, fat, and caloric content can also directly impair sleep quality. The immense consumer spend on snacks consumed before bed understandably has the attention of global snack giants such as Kellanova (NYSE: K), Nestle (OTC: NSRGY), Mondelez (NASDAQ: MDLZ), Post Holdings (NYSE: POST), and others.

Nightfood Holdings (OTCQB: NGTF) is pioneering the concept of sleep-friendly nighttime snacks and is largely alone in targeting an exploding consumer use case.  Nightfood is positioned to be the leader in the sleep-friendly nighttime snack category, which the brand is pioneering.  And now the company has made a move that signals new things to come which must not be overlooked.

In addition to its core sleep-friendly snack business, Nightfood has strategically focused on expanding its reach within the broader foodservice ecosystem. In July, the company announced a letter of intent to acquire CarryOutSupplies.com, a wholesale provider of packaging and supplies and to the foodservice industry. This move reflects NGTF’s ambition to become a comprehensive player in the sector.

Nightfood Holdings sees a golden opportunity in acquiring CarryOutSupplies.com right now. CarryOut is a well-established restaurant packaging distributor which has served a client base of over 7,000 foodservice and restaurant locations over the years.  The company is now bouncing back after COVID challenges.

CarryOut’s eco-friendly packaging solutions align perfectly with Nightfood’s focus on innovation and cater to a growing market trend. The reemerging company recorded sales of just over $2 million in calendar 2023, a positive sign, yet still a fraction of pre-COVID revenue. Nightfood believes CarryOut can not only regain pre-pandemic success but also surpass it, especially by targeting up and coming growth foodservice chains with CarryOut’s unique and eco-friendly packaging options.

A bolt-on of $2 million in sales certainly will look good in Nightfood’s books. The company launched robots-as-a-service (“RaaS”) model through its subsidiary, Future Hospitality Ventures Holdings, addressing labor cost and labor shortage in the hospitality industry.

As consumer preferences evolve and the demand for sleep-friendly options grows, Nightfood is well-positioned to capture a meaningful segment of the expanding late-night snacking market. By addressing the unmet needs of consumers with sleep-friendly snacks, Nightfood is not only shaping the future of the nighttime snacking category but also establishing itself as a major player in the broader landscape.

For more information, visit the company’s website at https://ir.nightfood.com/.

NOTE TO INVESTORS: The latest news and updates relating to NGTF are available in the company’s newsroom at http://ibn.fm/NGTF

Leaders of the pharma, biotech, and medical device healthcare industry, are invited to attend the 13th Advancing Women’s Leadership Skills & Opportunities In Pharma & Healthcare from September 23-25, 2024, in Philadelphia, PA.

This DGE program will focus on empowering women executives in leadership roles and closing the workplace gender gap. Success stories will be shared by women leaders who have succeeded after facing numerous career challenges. The event comprehensively offers insights into the life journeys of successful women, inspiring the attendees to overcome career hardships, achieve their goals, and seek the promotions they deserve.

The event is hosted by Dynamic Global Events (“DGE”), a Life Science leader in organizing b2b events. The global event company caters to the dynamic informational and networking needs of the Pharmaceutical, Biotechnology, Healthcare, Medical Devices, and allied industries.

Important “how to” topics to be covered:

• Strategies for Maneuvering the Landscape of the Board of Directors
• Break Through the Promotional Pipeline
• Cultivate Confidence – Tools to Improve Inner Belief and Executive Prescence
• Overcome Obstacles for Women’s Success: Generational Perspectives
• Maximize Opportunities to Shape Your Personal Brand
• Embracing Authentic Leadership and Passing It On to Teams
• Taking the High Road and Other Approaches for Getting Along at Work

The DGE conference includes keynote speaker sessions and discussion panels hosted by eminent industry leaders and women executives whose success journeys are an inspiration.

To know more, please visit https://ibn.fm/KMjev.

• Decentralized energy generation for specific geographic locations is growing in popularity as a solution for customers searching for climate-friendly alternatives
• Environmentally conscious corporations are likewise seeking solutions that will help them meet global sustainability goals and social and governance reporting
• Distributed energy solutions developer Correlate Energy Corp. is helping clients meet the challenges of the modern energy era, focusing on behind-the-meter solar infrastructure improvements, access to financing, and measurable progress in sustainable solutions
• Correlate Energy is using strategic partnerships to boost its ability to provide clients with data-driven responsiveness for decarbonization, site analysis, and design proposal needs

Companies worldwide are working to build environmental, social and governance (“ESG”) initiatives, while meeting the expectations of investors. A recent Deloitte survey indicates that a majority of US companies report progress on sustainability (https://ibn.fm/ZDILd).

At the same time, a recent Forbes column noted the difficulties that global corporations face in meeting deadlines and standards applied under a variety of agreements, ranging from the Corporate Sustainability Due Diligence Directive (“CSDDD”) in Europe to the Securities Exchange Commission’s (“SEC’s”) Climate Related Disclosure Standards in the U.S.

“The transition mandate in the CSDDD is a blessing in disguise for many firms because it will act as the impetus for a standard set of benchmarks for evaluating sustainability risk across supply chains and put some much-needed structure around data collection, reporting and actions,” the report states (https://ibn.fm/6E3ib). “That will, in turn, provide better insights for investors and consumers to evaluate each company’s real stance on sustainability on an apples-to-apples basis.”

Distributed energy solutions company Correlate Energy (OTCQB: CIPI) is making renewable energy measures more accessible for corporations and residential customers alike, increasing the incentive to make the transition to climate-friendly distributed energy systems.

As Correlate Energy develops its own localized clean energy solutions and microgrids, and helps clients figure out the best way to set up their own, it can connect them with sources of financing, manage the construction process, and ensure goals are being met while building reporting transparency in the process.

“Behind the meter solar … has been our focus for a long time, specifically on large commercial and industrial properties,” Correlate’s Solar Energy & Storage Director Jason Loyet said during a March webcast with analytics partner Xendee (https://ibn.fm/CbFKP). “I think a lot of developers and a lot of commercial sales people are getting approached by national portfolios — same with Correlate. We’re at a unique opportunity in the industry.”

Additionally, some utility clients are finding decentralized energy generation an attractive alternative to central grids beset by power outage problems insufficient infrastructure.

For more information, visit the company’s website at www.Correlate.Energy, including the following:

• Breaking Down Barriers To Your ESG Goals While Generating Additional Net Operating Income:  www.correlate.energy/our-process
• Platform Generates New Rent And Operating Income, Allowing You To Meet Your ESG Goals: www.correlate.energy/program

NOTE TO INVESTORS: The latest news and updates relating to CIPI are available in the company’s newsroom at https://ibn.fm/CIPI

• Fathom Nickel’s sprawling Gochager Lake Project covers 22,000+ hectares in the metal rich Trans-Hudson Corridor in Saskatchewan, Canada
• Located on the west side of the property about 10 kilometers from the Gochager deposit, the Mal Lake tenure hasn’t been explored since 1967; Fathom just re-evaluated available historic drill core
• The findings suggest similarities in nickel tenor, nickel-to-copper ratio, and even the source magma type between Mal Lake and Gochager Lake, hinting at a potential magmatic conduit system

Fathom Nickel (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) is pointing towards a bright future for its Gochager Lake property, thanks to recent core reviews at the nearby Mal Lake nickel occurrence. A recent press release highlights the exciting potential of the newly acquired Mal Lake tenure and its possible connection to the Gochager Lake deposit, both of which are part of Fathom’s more than 22,000-hectare Gochager Lake project in the Trans-Hudson Corridor in Saskatchewan.

Mal Lake’s Hidden Potential

The Gochager Lake Project is host to a historic, NI 43-101 non-compliant open pit resource consisting of 4.3 million tons at 0.295% nickel (Ni) and 0.081% copper (Cu). Mal Lake nickel occurrence is located on the eastern portion of the project, about 10 kilometers from the historic deposit.

Mal Lake hasn’t been explored since 1967. However, the historic Mal Lake drill core is available through the Saskatchewan Ministry of Energy and Resources’ Precambrian Geological Laboratory in La Ronge, SK. Recently, Fathom took a closer look at the drill core. Re-evaluation revealed significant zones of nickel-copper-cobalt mineralization.

This data suggests similarities in nickel tenor, nickel-to-copper ratio, and even the source magma type between Mal Lake and Gochager Lake.

Exploration Plans: Investigate Similarities

The close proximity (10km) and geological similarities between Mal Lake and Gochager Lake suggest a potential link between the two. Fathom plans to drill Mal Lake during the next winter program, considering it a drill-ready target.

The jump to drilling is based on several key findings in the drill core:

• Portable X-ray Fluorescence (“pXRF”) analysis of the Mal Lake core revealed zones with high nickel (over 10,000 ppm), copper, and cobalt (over 1,000 ppm) mineralization. Importantly, cobalt wasn’t analyzed during the original 1967 drilling
• Nickel-to-sulfur (Ni/S), nickel-to-copper (Ni/Cu), and nickel-to-cobalt (Ni/Co) ratios from Mal Lake pXRF data closely resemble those from Gochager Lake assays
• This similarity in ratios suggests both areas may have originated from the same magma source, potentially forming part of a larger magmatic conduit system

The proximity of Mal Lake and Gochager Lake hints at the existence of additional mineralized intrusions within the vast Gochager Lake property. Fathom believes the 2008 VTEM data speaks to the possibility of a controlling structure hosting these intrusions.

Unlocking the Blue-Sky Potential

This discovery opens doors for exploring a much larger area with significant potential for additional nickel deposits. By analyzing geophysical data, Fathom aims to identify more intrusions along the same magmatic conduit system.

This paves the way for substantial resource expansion at Gochager Lake and the discovery of new mineralized zones. Overall, Fathom Nickel’s exploration efforts at Mal Lake are shedding light on the immense potential of the Gochager Lake property. The company’s data-driven approach and planned drilling activities position them well to unlock the blue-sky potential of this exciting region.

For more information, visit the company’s website at www.FathomNickel.com.

NOTE TO INVESTORS: The latest news and updates relating to FNICF are available in the company’s newsroom at https://ibn.fm/FNICF

Meta Platforms (NASDAQ: META), a leading technology company, has been making headlines with its significant advancements in artificial intelligence (“AI”). The company’s CEO, Mark Zuckerberg, recently announced that Meta’s AI assistant is on track to become the most utilized in the world. This statement underscores the company’s commitment to AI technology and its potential to drive future growth. Meta, known for its social media platforms like Facebook and Instagram, is now positioning itself as a key player in the AI space, competing with other tech giants.

The recent performance of META’s stock reflects the dynamic nature of the tech industry. Despite the promising developments in AI, the company’s stock price experienced a decrease of 1.16% to $491.98. This change indicates the market’s immediate reaction to various factors, including the company’s strategic investments and the broader economic environment. The stock’s movement, with a low of $476.15 and a high of $501.15 during the trading session, showcases the volatility and investor sentiment surrounding tech stocks.

Over the past year, META’s stock has seen a wide range of prices, from a low of $274.38 to a high of $542.81. This fluctuation highlights the challenges and opportunities the company faces in a competitive and rapidly changing market. With a market capitalization of approximately $1.25 trillion, Meta Platforms remains a heavyweight in the tech industry, demonstrating the scale of its operations and its significant impact on the market.

The trading volume of 12.75 million shares further illustrates the active interest in META’s stock among investors. This level of activity is indicative of the market’s keen eye on Meta’s strategic moves, especially its investment in AI technology. As the company continues to develop its AI assistant and other innovative technologies, investors and the market at large will closely watch Meta’s performance for signs of long-term growth and profitability.

In summary, Meta Platforms’ focus on artificial intelligence is a strategic move that has the potential to redefine its role in the tech industry. Despite the recent dip in stock price, the company’s significant market capitalization and active trading volume reflect its enduring influence and the high stakes of its AI ambitions. As Meta continues to innovate, its journey offers valuable insights into the intersection of technology, investment, and market dynamics.

For more information, visit the company’s website at https://investor.FB.com.

The 4th Chief Patient Officer Summit held on July 15-16, 2024, was a resounding success, bringing together industry leaders, experts, and stakeholders to discuss and shape the future of patient-centric healthcare. The event featured insightful sessions, interactive panel discussions, and valuable networking opportunities, all aimed at enhancing patient engagement and care. 

Highlights from the Summit

Keynote Sessions: 

• Kay Matthews shared a “Trail Blazer Keynote: Knowledge Builds Community Trust”
• Beth Frates, MD, delivered an insightful keynote on “Restore – Recharge – Renew: PAVING the Path to Wellness: Thriving with a Healthy Body, Peaceful Mind and Joyful Heart
• Rene Russo, Pharm.D., presented an empowering Leadership Keynote Fireside Chat

Interactive Panels and Discussions: 

• Amplify Patient Voice in Market Access 
• Decode the Regulatory Pathway and Community Influence in Regulatory Decision-Making
• Elevate Equity from Inception and Sustain Inclusion through Post Marketing 
• Operationalize Patient-Inclusivity: Anticipate, Minimize, and Exit the “Sticky Middle” 
• Drive Community Health Equity by Uniting National and Local Collaborations 
• Patient Assistance: What You Should Know As A Patient Advocate 
• Gain Techniques for Successful Measurement and Reporting 
• Examine Publishing Trends with Partners
• Red Cell Revolution Reveals Authentic Patient Engagement

On-Demand Access Now Available 

For those who couldn’t attend or want to revisit the valuable content, we are pleased to announce that on-demand access is now available. Attendees can register to watch the entire summit from anywhere, at any time. This flexible option ensures that you don’t miss out on the wealth of knowledge and insights shared during the event. Register for on-demand access.

Looking Ahead 

We extend our gratitude to all speakers, sponsors, and participants for making the Chief Patient Officer Summit a memorable and impactful event. As we continue to champion patient-centered healthcare, save the date for Chief Patient Officer Summit West on January 29-30, 2025, in San Diego, CA.

Learn more information and register for upcoming events with Dynamic Global Events.

• ECGI Holdings is a diversified holding company focusing on viticulture, luxury fashion, and equestrian markets
• The company believes the luxury apparel and accessories segments, which excludes broader categories like watches, jewelry, and beauty, constitute about 50% of the luxury market in the U.S. and possibly globally
• The luxury apparel and accessories segments are valued at approximately $37 billion in the U.S., which would translate to revenues of between $370 million and $1.85 billion for companies that achieve a market share of 1-5%
• The luxury equestrian market offers a path to the much greater overall luxury and overall equestrian markets, where significant revenues are available without having to become a major player as would be the case in a smaller market

The fashion world is filled brands, but only a few tick all the boxes that confer luxury status. Indeed, luxury is a special segment of the fashion market comprising products that, though expensive, need not be overpriced. As an article in Forbes explains (https://ibn.fm/4bn3Y), “Expensive merely reflects the quality of the unique designs, fine materials, and excellent workmanship. Similarly, luxury is not faddish but long lasting.” Additionally, the article explains, luxury brands have a limited distribution and attach a high level of service to the sale, with salespeople striving to know and understand their customers’ tastes and sizes.

The mention of luxury brings to mind the best known brands and labels, from Tiffany, Ralph Lauren (NYSE: RL), Louis Vuitton (OTC: LVMHF), and Hermès (OTC: HESAF), to Gucci, Channel, Dior, Balenciaga, and Armani. Some luxury brands share a love for equestrian themes, with their in-house designers incorporating equestrian inspirations, details, and motifs into a panoply of products, from glossy, knee-length leather boots and sleek-fitting jodhpurs. to blazers and jackets. In addition, fashion accessories like buckles, belts, and bags have been similarly inspired by the equestrian world (https://ibn.fm/XSDvc).

Collectively, these brands, and the quality products that they design, make, and sell, form a dynamic part of the global luxury goods market, valued at about $354.81 billion in 2023. Statista predicts the market will reach $368.94 billion by the end of this year and $418.89 billion by 2028. The luxury fashion segment accounted for $111.5 billion of this revenue in 2023, a figure that is projected to grow to $115.9 billion in 2024 and $131.7 billion by 2028 (https://ibn.fm/cTRtH).

Moreover, Statista further notes that the U.S. generates the highest revenue, making it the largest market for luxury goods globally. For example, the country is set to contribute $77.28 billion in revenue in 2024, up from $75.68 billion in 2023. Statista expects the U.S. luxury goods market to generate $83.32 billion in revenue by 2028. And like the worldwide market, luxury fashion in the U.S. accounts for the biggest share of the luxury goods market (https://ibn.fm/hgPNF).

For ECGI Holdings (OTC: ECGI), a diversified holding company focusing on viticulture, luxury fashion, and equestrian markets, the largest segments of the luxury goods market represent an opportunity to generate significant annual revenues. The company bases this belief on the understanding that the luxury apparel and accessories segments (excluding broader categories like watches, jewelry, and beauty) constitute about 50% of the luxury market in the U.S. and possibly globally.

Basing the calculations on Statista’s projections, these segments would be valued at $37.84 billion in 2023 and $38.64 billion in 2024. In this regard, by focusing on the luxury apparel and accessories segments, equestrian companies like ECGI Holdings’ Pacific Saddlery can strategically target a market valued at over $37 billion in the U.S. If such a company were to achieve a market share of 1-5% in these segments, it could realize significant annual revenues of between $370 million and $1.85 billion. This, ECGI Holdings believes, highlights the substantial opportunity for growth and expansion beyond traditional equestrian products.

These targets are achievable if the revenues posted by several major companies that have already established a strong presence in the luxury equestrian apparel and accessories market are anything to go by. For instance, Hermès, a French luxury goods manufacturer, generated total revenues of $14.52 billion (€13.43 billion) in fiscal 2023 (https://ibn.fm/v6Ncz), while Ralph Lauren, an American luxury fashion brand, reported total revenue of $6.6 billion in fiscal 2024 (https://ibn.fm/sSanj). On the other hand, Gucci, an Italian luxury fashion house that is part of the Kering Group, reported revenues of approximately €9.9 billion ($10.7 billion) in 2023 (https://ibn.fm/jRsu1).

Though established, Hermès, Gucci, and Ralph Lauren are part of a large market that ECGI Holdings is targeting. The holding company believes it can achieve a market share in this large market, however marginal, that enables it to earn significant revenues without having to become a major player, as would have been the case in a smaller market. To bring it closer to achieving this target, ECGI Holdings recently announced a new collection of ready-to-wear equestrian apparel under Pacific Saddlery’s celebrated Allon brand. This move aligns with the company’s strategy to expand its presence in the luxury equestrian sector, said Jamie Steigerwald, CEO of ECGI, in the June 25 announcement (https://ibn.fm/W442w).

For more information, visit the company’s website at www.ECGIHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to ECGI are available in the company’s newsroom at https://ibn.fm/ECGI

• A recent report projects that the cannabis market, which totaled an estimated $27.7 billion in 2022, will reach $82.3 billion by 2027
• The forecast includes businesses and enterprises involved in the cultivation, processing, distribution and sale of cannabis and cannabis-related products
• MedCana is building technology, laboratories, growing facilities and scientific teams to provide premium pharmaceutical-grade cannabis extracts to the world

With the worldwide cannabis market projected to see a compound annual growth rate (“CAGR”) of 24.3% in the next three years, Software Effective Solutions (d/b/a MedCana) (OTC: SFWJ) is committed to strengthening its foothold in the growing space. The company, which is committed to being a global force for better cannabis products, is determined to be the world’s premier resource for pharmaceutical cannabis products.

“The cannabis market is estimated at $27.7 billion in 2022 and is projected to reach $82.3 billion by 2027, at a CAGR of 24.3%,” reported a MarketsandMarkets article earlier this year (https://ibn.fm/3Vx5z). “In recent years, the cannabis industry has experienced significant growth and expansion, driven by increasing legalization efforts in various parts of the world, shifting public attitudes towards cannabis use and recognition of its potential medicinal benefits. This growth has led to the emergence of a diverse range of companies, including large-scale producers, dispensaries, manufacturers of cannabis-derived pharmaceuticals, technology firms developing innovative cultivation and extraction methods, and ancillary businesses providing services such as packaging, branding, and legal support.”

Noting that the term “cannabis industry” refers to the collection of businesses and enterprises involved in the cultivation, processing, distribution and sale of cannabis and cannabis-related products, the article outlines several factors likely to contribute to the sector’s growth, including legalization efforts, product innovation, investment and M&A activity, and the regulatory landscape.

The article also noted that “the medical cannabis segment is expected to continue growing, driven by increasing recognition of cannabis’s therapeutic properties and its potential to treat various medical conditions. Pharmaceutical companies are also investing in cannabis-based medications, contributing to market expansion.” In addition, “The recreational cannabis market is [also] forecasted to see continued growth, particularly in regions where legalization has occurred or is expected. Changing attitudes towards cannabis use and increasing consumer acceptance are key drivers in this segment.”

These factors all point to a promising cannabis sector moving forward, with MedCana committed to doing the work necessary to become a leader in the space. The company is building the technology, laboratories, growing facilities and scientific teams needed to provide premium pharmaceutical-grade cannabis extracts to the world, all with absolute integrity, sustainability and social responsibility (https://ibn.fm/gfM4F).

MedCana is a global infrastructure and holding company in the cannabis industry. The company currently has five divisions focused on pharmaceutical cannabis production, as well a software division focused on managing processes for plant-to-patient operations. The recent acquisition of an irrigation and greenhouse technology division has rounded out MedCana’s portfolio of holdings.

For more information, visit the company’s website at www.MedCana.net.

NOTE TO INVESTORS: The latest news and updates relating to SFWJ are available in the company’s newsroom at https://ibn.fm/SFWJ

• SuperCom Ltd. is an electronic monitoring solutions company working with governments and justice system officials to promote public safety through the secure tracking of suspects and convicted offenders
• SuperCom has a particular interest in seeing tools in its PureSecurity Suite platform devoted to protecting victims of DV (domestic violence) by tracking offenders and thereby enforcing court-issued protective orders
• The quality of SuperCom’s technology and related services has bolstered its reputation, helping it to secure an additional $11 million in new contract revenue during the past few months

Electronic monitoring (“EM”) technology is finding a place as a significant and accessible solution for preventing domestic violence.

A recent fact sheet from StalkingAwareness.org (https://ibn.fm/yN3B0) shows a particular need for enforcing protective orders worldwide to prevent stalking and associated DV. The report shows that 74 percent of those individuals who are stalked by a “former intimate partner” indicated that they had experienced violence or coercive control during their relationship. Among homicide and attempted homicide victims who had experienced physical abuse during a relationship, 89 to 91 percent were also stalked by the partner, and 46 to 54 percent of homicide, or attempted homicide victims let police or someone else know that they were being stalked prior to the attack.

Concern about the dangers to domestic violence victims is further evident in the U.S. Supreme Court’s recent ruling that upheld a gun control law designed to help domestic violence victims as a “common sense” measure, despite the court’s prior decisions expanding gun use rights (https://ibn.fm/z0yUT).

“Since the founding, our nation’s firearm laws have included provisions preventing individuals who threaten physical harm to others from misusing firearms,” Chief Justice John Roberts stated in conjunction with the ruling.

EM technology innovator SuperCom (NASDAQ: SPCB) has developed an array of tools designed to provide crucial information on offenders’ and victims’ movements to enforce court restrictions and safeguard victims. The tracking technology in the company’s PureSecurity Suite platform can provide three-dimensional information on movements and works in conjunction with a smartphone app that provides the information directly to the victim. “People have been trying to do electronic monitoring for over 30 years, but many of the times they ran into technological hurdles,” SuperCom President and CEO Ordan Trabelsi said during a Your Advantage Play podcast interview (https://ibn.fm/GWqkl). “With every project, we’re able to be one step ahead of the curve.”

Proponents of EM tracking technology emphasize the necessity for its effectiveness. A recent UK case demonstrated this need when the offender was arrested after he was found to have been stalking despite court-ordered police monitoring but monitoring that focused largely on simply reviewing the offender’s phone activity. “(The offender’s) reoffending began almost immediately following the issuing of the (court protective) order, which was put in place less than five days before to protect a vulnerable person who had been the subject of domestic abuse,” the Police Constable said (https://ibn.fm/tWTnq). 

SuperCom provides additional monitoring services to accompany its technology suite and tailors its services to each client’s needs. During the past three months, the company received new orders from European governments worth a total of over $11 million in sales, evidence of SuperCom’s growing popularity and staying power.

For more information, visit the company’s website at www.SuperCom.com.

NOTE TO INVESTORS: The latest news and updates relating to SPCB are available in the company’s newsroom at http://ibn.fm/SPCB